{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:41:58Z","timestamp":1767148918140,"version":"build-2238731810"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.juro.2011.07.107","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T01:28:55Z","timestamp":1319506135000},"page":"2426-2433","source":"Crossref","is-referenced-by-count":7,"title":["Potentiation of Mitomycin C Tumoricidal Activity for Transitional Cell Carcinoma by Histone Deacetylase Inhibitors In Vitro [RETRACTED]"],"prefix":"10.1097","volume":"186","author":[{"given":"Abdalla Ali","family":"Deb","sequence":"first","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shandra S.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle O.","family":"Rove","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweaty","family":"Koul","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas D.","family":"Lim","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall B.","family":"Meacham","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari K.","family":"Koul","sequence":"additional","affiliation":[{"name":"Program in Urosciences, Division of Urology, Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.07.107_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM195505262522101","article-title":"Chemotherapy of solid tumors with trimethylene thiophosphoramide","volume":"252","author":"Bateman","year":"1955","journal-title":"New Engl J Med"},{"key":"10.1016\/j.juro.2011.07.107_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-5347(02)80294-4","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"167","author":"Morales","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.07.107_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0895-4356(99)00203-6","article-title":"Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials","volume":"53","author":"Huncharek","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2011.07.107_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.07.107_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.50.2.355","article-title":"A molecular mechanism of mitomycin action: linking of complementary DNA strands","volume":"50","author":"Iyer","year":"1963","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.juro.2011.07.107_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","article-title":"Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses","volume":"36","author":"Shelley","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.juro.2011.07.107_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.02.042","article-title":"Enhancing the apoptotic and therapeutic effects of HDAC inhibitors","volume":"280","author":"Frew","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.juro.2011.07.107_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2009.02.045","article-title":"Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines","volume":"281","author":"Byun","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.juro.2011.07.107_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentary","volume":"37","author":"Johanssen","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.juro.2011.07.107_bib10","first-page":"97","article-title":"Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-a","volume":"20","author":"Cinatl","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.juro.2011.07.107_bib11","doi-asserted-by":"crossref","first-page":"31674","DOI":"10.1074\/jbc.M104309200","article-title":"The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth","volume":"276","author":"Yuan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2011.07.107_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","article-title":"Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase","volume":"83","author":"Bacon","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.juro.2011.07.107_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/neuonc\/4.2.95","article-title":"Histone acetylation may suppress human glioma cell proliferation when p21 WAF\/Cip1 and gelsolin are induced","volume":"4","author":"Kamitani","year":"2002","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.juro.2011.07.107_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11010-007-9511-9","article-title":"Radiosensitization by diospyrin diethylether in MCF-7 breast carcinoma cell line","volume":"304","author":"Kumar","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.juro.2011.07.107_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ymthe.2005.10.005","article-title":"Second generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity","volume":"13","author":"Barton","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.juro.2011.07.107_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.juro.2011.07.107_bib17","doi-asserted-by":"crossref","first-page":"34940","DOI":"10.1074\/jbc.274.49.34940","article-title":"Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects","volume":"274","author":"Sambucetti","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2011.07.107_bib18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2401508","article-title":"Histone deacetylase inhibitors are the potent inducer\/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy","volume":"13","author":"Kosugi","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.juro.2011.07.107_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.20045","article-title":"Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid","volume":"92","author":"Marchion","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.juro.2011.07.107_bib20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1200\/JCO.2006.09.8293","article-title":"Addition of histone deacetylase inhibitors in combination therapy","volume":"25","author":"Carraway","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.07.107_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archophthalmol.2009.64","article-title":"In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells","volume":"127","author":"Cunneen","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.juro.2011.07.107_bib22","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood-2006-03-009142","article-title":"Phase 1\/2 study of the combination of 5-aza-2\u2032-deoxycytidine with valproic acid in patients with leukemia","volume":"108","author":"Garcia-Manero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.juro.2011.07.107_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1179\/joc.2006.18.4.415","article-title":"Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer","volume":"18","author":"Friedmann","year":"2006","journal-title":"J Chemother"},{"key":"10.1016\/j.juro.2011.07.107_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000421-199810000-00019","article-title":"Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: Phase II studies by the eastern cooperative oncology group","volume":"21","author":"Rosenthal","year":"1998","journal-title":"Am J Clin Oncol"}],"updated-by":[{"DOI":"10.1097\/ju.0000000000001959","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"record-id":"30862"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471104537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471104537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.07.107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:26:31Z","timestamp":1651184791000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.07.107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1016\/j.juro.2011.07.107"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.07.107","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}